✦ LIBER ✦

Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens

✍ Scribed by R. F. OZOLS

Book ID: 114730185
Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 633 KB
Volume: 10
Category: Article
ISSN: 0105-6263
DOI: 10.1111/j.1365-2605.1987.tb00196.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage, dose intense and high-dose chem

Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours

✍ L. El-Helw; R.E. Coleman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Bleomycin, vincristine, cisplatin/bleomy

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours

✍ Anthoney, D A; McKean, M J; Roberts, J T; Hutcheon, A W; Graham, J; Jones, W; Pa 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

High-dose chemotherapy and reinfusion of

High-dose chemotherapy and reinfusion of haematopoietic stem cells advanced germ cell tumours with poor prognosis in 1996

✍ Pont, J.; Höltl, W.; Weißbach, L.; Beyer, J.; Siegert, W. 📂 Article 📅 1997 🏛 Springer 🌐 German ⚖ 190 KB

High-dose chemotherapy with haematopoiet

High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours

✍ LOAIE M. EL-HELW; JAY D. NAIK; JOHN D. CHESTER; JOHNATHAN K. JOFFE; PETER J. SEL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Treatment of poor prognosis nonseminomat

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

✍ Robert F. Ozols; Albert B. Deisseroth; Nasser Javadpour; Audrey Barlock; Gerald 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

A new intensive four drug combination chemotherapy regimen, termed PVeBV, consisting of cis-plathum, vinblastine, bleomycin, and VP-16, was administered to six previously untreated patients with poor prognosis advanced nonseminomatous testicular cancer and to four patients who had relapsed on primar

Treatment of patients with poor prognosi

Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites

✍ E. S. NEWLANDS; K. D. BAGSHAWE; R. H. J. BEGENT; G. J. S. RUSTIN; S. M. CRAWFORD 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB